Cargando…
Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
Background: N(6)-methyladenosine (m6A) modification is a dynamic and reversible post-transcriptional RNA modification prevalent in eukaryotic cells. YT521-B homology domain family 2 (YTHDF2) has been identified as a member of m6A reader protein involving in many vital biological processes, whereas i...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470763/ https://www.ncbi.nlm.nih.gov/pubmed/36120577 http://dx.doi.org/10.3389/fcell.2022.954214 |